FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362595498> ?p ?o ?g. }

• W4362595498 endingPage "6785" @default.
• W4362595498 startingPage "6785" @default.
• W4362595498 abstract "Abstract Introduction: Multiple myeloma (MM), a clonal disorder of terminally differentiated plasma cells, is the second most common hematologic malignancy with ~57.9% 5-year survival rate. Current MM therapies are not curative and in most patients MM relapse. Aiming to restore antitumor immunity and counteract MM evolution, we have developed a personalized dendritic(DC)/MM cell fusion vaccine, whereby several tumor antigens are presented in the context of DC mediated co-stimulation. BMT CTN 1401 is a multicenter randomized phase II clinical trial (NCT02728102) evaluating the efficacy of the DC/MM vaccine combined with lenalidomide maintenance (Len) after autoHCT. 203 patients were enrolled from 18 centers. Aim: To evaluate the impact of the DC/MM vaccine on the establishment of anti-MM immune response we profiled the peripheral blood (PB) immune landscape at the single-cell level, with particular focus on the T cell compartment. Method: We performed single-cell immunoprofiling (gene expression + V(D)J sequencing) on 40 patients (3xDC/MM vaccine/Len/GM-CSF: N=20; Len/GM-CSF: N=10; Len: N=10). 160 PB mononuclear cells (PBMC) samples were collected at enrollment, prior to Len, after 1 and 3 vaccines and were processed using the 10x Genomics single cell 5' assay. Here we present the analysis relative to 52 PBMC samples from 13 vaccinated patients included in the initial study cohort. The remaining 108 PBMC samples have already been subjected to single-cell immunoprofiling and the analysis is ongoing. Results: 309,423 cells passed quality-check identifying 47 cell populations, corresponding to 20 major compartments. The T cell compartment (146,373 cells) was divided into 14 different cell populations including activated CD8, CD4, and NKT cells that exhibited a gradual increase during the course of the study. Relatively, TCR sequencing demonstrated a recovery of T cell clonal diversity and a progressive rise in the frequency of expanded clonotypes within the activated CD4 and cytotoxic T cell populations after vaccination. Consistently, we observed a progressively raised number of shared TCR clonotypes within the activated CD8 and CD4 T cell subsets. The identification of common epitope/paratope hotspots among the expanded clonotypes and the different patients revealed a higher proportion of shared TCR clonotype groups across patients after vaccination compared to the early post-transplant period, predominantly after 3 vaccinations. Conclusions: Assessment of PBMC samples from 13 vaccinated patients provided a detailed picture of the PBMC landscape. The constant T cell expansion in patients following vaccination coupled with the shared paratope/epitope hotspots and TCR signatures among patients indicated the TCR cross-reactivity and suggested for the establishment of an anti-MM immune response. Citation Format: Giulia Cheloni, Dimitra Karagkouni, Daniela Torres, David J. Chung, Nina Shah, Natalie S. Callander, Thinle Chodon, Yvonne Efebera, Nancy Geller, Peiman Hematti, Hillard Lazarus, Ehsan Malek, Philip L. McCarthy, Ajay K. Nooka, Jacalyn Rosenblatt, Aaron P. Rapoport, Robert J. Soiffer, Dina Stroopinsky, Edmund K. Waller, Marcelo C. Pasquini, Ioannis Vlachos, David Avigan. Dendritic cell/myeloma fusion vaccine with lenalidomide maintenance following autologous hematopoietic cell transplant induced T cell activation and expansion [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 6785." @default.
• W4362595498 created "2023-04-06" @default.
• W4362595498 creator A5011386306 @default.
• W4362595498 creator A5018739151 @default.
• W4362595498 creator A5020529918 @default.
• W4362595498 creator A5022520524 @default.
• W4362595498 creator A5025607600 @default.
• W4362595498 creator A5027037495 @default.
• W4362595498 creator A5040185213 @default.
• W4362595498 creator A5042200100 @default.
• W4362595498 creator A5042432109 @default.
• W4362595498 creator A5042613823 @default.
• W4362595498 creator A5052641327 @default.
• W4362595498 creator A5053904944 @default.
• W4362595498 creator A5054346063 @default.
• W4362595498 creator A5057983232 @default.
• W4362595498 creator A5058362903 @default.
• W4362595498 creator A5063351800 @default.
• W4362595498 creator A5068050082 @default.
• W4362595498 creator A5080097660 @default.
• W4362595498 creator A5080153027 @default.
• W4362595498 creator A5083283435 @default.
• W4362595498 creator A5086815330 @default.
• W4362595498 creator A5087727695 @default.
• W4362595498 date "2023-04-04" @default.
• W4362595498 modified "2023-09-30" @default.
• W4362595498 title "Abstract 6785: Dendritic cell/myeloma fusion vaccine with lenalidomide maintenance following autologous hematopoietic cell transplant induced T cell activation and expansion" @default.
• W4362595498 doi "https://doi.org/10.1158/1538-7445.am2023-6785" @default.
• W4362595498 hasPublicationYear "2023" @default.
• W4362595498 type Work @default.
• W4362595498 citedByCount "0" @default.
• W4362595498 crossrefType "journal-article" @default.
• W4362595498 hasAuthorship W4362595498A5011386306 @default.
• W4362595498 hasAuthorship W4362595498A5018739151 @default.
• W4362595498 hasAuthorship W4362595498A5020529918 @default.
• W4362595498 hasAuthorship W4362595498A5022520524 @default.
• W4362595498 hasAuthorship W4362595498A5025607600 @default.
• W4362595498 hasAuthorship W4362595498A5027037495 @default.
• W4362595498 hasAuthorship W4362595498A5040185213 @default.
• W4362595498 hasAuthorship W4362595498A5042200100 @default.
• W4362595498 hasAuthorship W4362595498A5042432109 @default.
• W4362595498 hasAuthorship W4362595498A5042613823 @default.
• W4362595498 hasAuthorship W4362595498A5052641327 @default.
• W4362595498 hasAuthorship W4362595498A5053904944 @default.
• W4362595498 hasAuthorship W4362595498A5054346063 @default.
• W4362595498 hasAuthorship W4362595498A5057983232 @default.
• W4362595498 hasAuthorship W4362595498A5058362903 @default.
• W4362595498 hasAuthorship W4362595498A5063351800 @default.
• W4362595498 hasAuthorship W4362595498A5068050082 @default.
• W4362595498 hasAuthorship W4362595498A5080097660 @default.
• W4362595498 hasAuthorship W4362595498A5080153027 @default.
• W4362595498 hasAuthorship W4362595498A5083283435 @default.
• W4362595498 hasAuthorship W4362595498A5086815330 @default.
• W4362595498 hasAuthorship W4362595498A5087727695 @default.
• W4362595498 hasConcept C126322002 @default.
• W4362595498 hasConcept C137061746 @default.
• W4362595498 hasConcept C143998085 @default.
• W4362595498 hasConcept C147483822 @default.
• W4362595498 hasConcept C151730666 @default.
• W4362595498 hasConcept C202751555 @default.
• W4362595498 hasConcept C203014093 @default.
• W4362595498 hasConcept C2776063141 @default.
• W4362595498 hasConcept C2776090121 @default.
• W4362595498 hasConcept C2776364478 @default.
• W4362595498 hasConcept C2778170410 @default.
• W4362595498 hasConcept C2779343474 @default.
• W4362595498 hasConcept C55493867 @default.
• W4362595498 hasConcept C71924100 @default.
• W4362595498 hasConcept C86803240 @default.
• W4362595498 hasConcept C8891405 @default.
• W4362595498 hasConceptScore W4362595498C126322002 @default.
• W4362595498 hasConceptScore W4362595498C137061746 @default.
• W4362595498 hasConceptScore W4362595498C143998085 @default.
• W4362595498 hasConceptScore W4362595498C147483822 @default.
• W4362595498 hasConceptScore W4362595498C151730666 @default.
• W4362595498 hasConceptScore W4362595498C202751555 @default.
• W4362595498 hasConceptScore W4362595498C203014093 @default.
• W4362595498 hasConceptScore W4362595498C2776063141 @default.
• W4362595498 hasConceptScore W4362595498C2776090121 @default.
• W4362595498 hasConceptScore W4362595498C2776364478 @default.
• W4362595498 hasConceptScore W4362595498C2778170410 @default.
• W4362595498 hasConceptScore W4362595498C2779343474 @default.
• W4362595498 hasConceptScore W4362595498C55493867 @default.
• W4362595498 hasConceptScore W4362595498C71924100 @default.
• W4362595498 hasConceptScore W4362595498C86803240 @default.
• W4362595498 hasConceptScore W4362595498C8891405 @default.
• W4362595498 hasIssue "7_Supplement" @default.
• W4362595498 hasLocation W43625954981 @default.
• W4362595498 hasOpenAccess W4362595498 @default.
• W4362595498 hasPrimaryLocation W43625954981 @default.
• W4362595498 hasRelatedWork W1505169546 @default.
• W4362595498 hasRelatedWork W2001055320 @default.
• W4362595498 hasRelatedWork W2031356189 @default.
• W4362595498 hasRelatedWork W2043505088 @default.
• W4362595498 hasRelatedWork W2220102944 @default.
• W4362595498 hasRelatedWork W2381196212 @default.
• W4362595498 hasRelatedWork W2938456301 @default.
• W4362595498 hasRelatedWork W3113412439 @default.

• next